Back to results
US 2023/0148349 A1Published application
Humanized antibody against o-acetylated gd2 ganglioside (oacgd2)
AssigneeOgd2 Pharma
InventorsMickaël TERME, Jean-Marc LE DOUSSAL, Mylene DORVILLIUS, Brigitte ASSOULINE
Life of this patent
Estimating the term…
Abstract
Disclosed is an antibody, functional fragment, and derivative thereof, which binds specifically to the OAcGD2 ganglioside, the antibody including i) a humanized light chain variable region (VL) polypeptide having the amino acid sequence SEQ id n°112; and ii) a humanized heavy chain variable region (VH) having the amino acid sequence SEQ id n°76; and its use in diagnostics and therapy.
Claims20
An antibody, functional fragment, and derivative thereof, which binds specifically to the O-acetylated GD2 (OAcGD2) ganglioside, said antibody comprising:
- a) a humanized light chain variable region (VL) polypeptide having the amino acid sequence SEQ id n°112;
- and
- b) a humanized heavy chain variable region (VH) having the amino acid sequence SEQ id n°76.
Dependencies are inferred from the claim text.